Oriol Juan-Babot Selected Research

Oriol Juan-Babot Research Topics

Disease

5	Atherosclerosis 05/2021 - 07/2004
5	Thrombosis (Thrombus) 01/2017 - 07/2004
4	Myocardial Infarction 04/2015 - 09/2009
3	Fibrosis (Cirrhosis) 08/2014 - 03/2011
3	Hypoxia (Hypoxemia) 08/2012 - 05/2008
2	Inflammation (Inflammations) 05/2021 - 03/2011
2	Reperfusion Injury 07/2016 - 08/2014
2	Cicatrix (Scar) 08/2014 - 10/2012
2	Ischemia 08/2014 - 03/2011
2	Atherosclerotic Plaque (Atheroma) 09/2009 - 07/2004
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 05/2021
1	Vascular Remodeling 05/2021
1	Heart Failure 01/2019
1	Vascular System Injuries 06/2015
1	ST Elevation Myocardial Infarction 04/2015
1	Acute Coronary Syndrome 08/2014
1	Infarction (Infarctions) 10/2012
1	Cardiomyopathies (Cardiomyopathy) 08/2012
1	Hypercholesterolemia 10/2011
1	Hypertension (High Blood Pressure) 10/2011
1	Brain Ischemia (Cerebral Ischemia) 01/2007
1	Stroke (Strokes) 01/2007
1	Ischemic Stroke 01/2007

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2007
4	LipidsIBA 05/2021 - 11/2011
4	CollagenIBA 08/2014 - 07/2004
4	Messenger RNA (mRNA)IBA 08/2014 - 01/2007
3	Cholesterol Esters (Cholesteryl Esters)IBA 10/2012 - 06/2011
2	Lipoproteins (Lipoprotein)IBA 05/2021 - 08/2012
2	GelsolinIBA 01/2017 - 06/2015
2	Simvastatin (Zocor)FDA LinkGeneric 08/2014 - 10/2011
2	Caspase 3 (Caspase-3)IBA 08/2014 - 03/2011
2	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 08/2014 - 09/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2014 - 09/2009
2	oxidized low density lipoproteinIBA 08/2012 - 11/2011
2	CholesterolIBA 08/2012 - 10/2011
2	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 08/2012 - 06/2011
2	LDL Receptors (LDL Receptor)IBA 11/2011 - 10/2011
1	Complement C3 (C3 Complement)IBA 05/2021
1	Myosins (Myosin)IBA 01/2017
1	PeroxiredoxinsIBA 01/2017
1	TropomyosinIBA 01/2017
1	Superoxide DismutaseIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 06/2015
1	RoflumilastIBA 06/2015
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 06/2015
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 06/2015
1	Endothelin-1 (Endothelin 1)IBA 06/2015
1	ProteomeIBA 06/2015
1	ClusterinIBA 06/2015
1	Blood Proteins (Serum Proteins)IBA 04/2015
1	Profilins (Profilin)IBA 04/2015
1	hydroxide ionIBA 08/2014
1	Triglycerides (Triacylglycerol)IBA 10/2012
1	Apolipoproteins B (ApoB)IBA 10/2012
1	Thromboplastin (Tissue Factor)IBA 11/2011
1	Low Density Lipoprotein Receptor-Related Protein-5IBA 11/2011
1	LDL Lipoproteins (beta Lipoproteins)IBA 06/2011
1	LuciferasesIBA 06/2011
1	Matrix Metalloproteinases (MMPs)IBA 03/2011
1	CytokinesIBA 03/2011
1	ChemokinesIBA 03/2011
1	Metalloproteases (Metalloproteinases)IBA 03/2011
1	Indicators and Reagents (Reagents)IBA 09/2009
1	EndoglinIBA 05/2008
1	C-Reactive ProteinIBA 05/2008
1	AntibodiesIBA 05/2008
1	Interleukin-6 (Interleukin 6)IBA 05/2008
1	ParaffinIBA 05/2008
1	Cyclin-Dependent Kinase 5IBA 01/2007
1	Oxygen (Dioxygen)IBA 01/2007
1	Glucose (Dextrose)FDA LinkGeneric 01/2007
1	saratinIBA 07/2004
1	FibrinIBA 07/2004

Therapy/Procedure

2	Therapeutics 05/2021 - 01/2019
1	Stents 01/2017
1	Ischemic Postconditioning 07/2016
1	Thrombectomy 04/2015
1	Oral Administration 08/2014
1	Percutaneous Coronary Intervention 08/2014